Skip to main content
Fig. 3 | Human Genomics

Fig. 3

From: Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response

Fig. 3

Heatmap depicting DMRs upon comparing individuals with RAEBI MDS subtype against individuals with MDS but without an excess of blasts (A). Another heatmap depicting DMRs upon comparing individuals with RAEBI MDS subtype against individuals with MDS but without an excess of blasts (B). Heatmap depicting DMRs upon comparing individuals with RAEBII MDS subtype against individuals with RAEBII MDS subtype (C). Network map (D) depicting interactions between DMRs with fold change values above 3.5 and other proteins involved in molecular pathways. These DMRs are also found within the heatmaps (A, B, C). RAEBI: S1, S2, S3; RAEBII: S4, S5, S6, S7; MDS without an excess of blasts: S8, S9, S10, S11

Back to article page

Human Genomics

ISSN: 1479-7364